PT Staff

Study finds textured breast implants do not increase the risk of anaplastic large-cell lymphoma, which has grown in incidence since 2008.

Study finds men are more likely to be prescribed statins and women are more likely to be advised to make lifestyle changes to lessen the risk of cardiovascular disease.

Implants could produce and deliver monoclonal anti-HIV antibody therapy for at least 1 year.

The current flu hospitalization rate is the highest observed this early in a flu season in over a decade.

Zuranolone is a rapid-acting, once-daily, 14-day oral short course therapy for adult patients with major depressive disorder and postpartum depression.

Omega-3 fatty acids among the micronutrients found to provide a benefit to cardiovascular health.

PHP shows promise extending survival in patients with inoperable intrahepatic cholangiocarinomas or extrahepatic cholangiocarinoma with liver metastases.

Nearly half of the study population received a first-time hypertension diagnosis post hospitalization, with approximately half of these new cases occurring more than 6 weeks postpartum.

New system may more accurately identify IVIG resistance in North American patients with Kawasaki disease than the Kobayashi score.

Interventions such as mask-wearing and social distancing have been found effective at limiting the spread of respiratory diseases.

Psoriasis with coexistent lupus erythematosus is uncommon, shows a female preponderance, and is more likely to have joint involvement from both conditions.

A recent study did not find a significant association between a healthy plant-based diet and the risk for colorectal cancer among 93,475 US women.

Novel mutations in the gene GTF3A impairs the innate immune response to herpes simplex virus 1.

Inhibiting the lipid kinase VPS34 may improve the treatment of diseases such as diabetes and kidney cancer.

Muscle pain is a significant reason why many patients fail to remain adherent to their statin medication regimen.

Study does not show a statistically significant association for specific cardiovascular outcomes related to cardiac arrest or arrhythmias, cerebrovascular diseases, or myocardial infarction associated with medications for attention-deficit hyperactivity disorder.

Atogepant is an oral calcitonin gene-related peptide receptor antagonist approved in 2021 for patients with episodic migraines.

Tenofovir alafenamide (Vemlidy; Gilead Science) approved for the treatment of chronic hepatitis B virus infection in pediatric patients aged 12 years and older with compensated liver disease.

Benzonatate overdoses were reported in children under 2 years of age after accidentally ingesting as few as 1-2 capsules.

Lipid pathways have been implicated in the pathogenesis of psoriasis and some lipid lowering drugs are believed to have disease-modifying properties.

Nearly 8 out of 10 individuals within the recommended age range for colorectal cancer screening are considered to have an average risk for the disease.

Olutasidenib (Rezlidhia) is indicated for adult patients with relapsed or refractory acute myeloid leukemia with a susceptible IDH1 mutation detected by an FDA-approved test.

Live-jslm (Rebyota; Ferring Pharmaceuticals) is indicated for the prevention of recurring Clostridioides difficile infection among patients 18 years of age and older after an antibiotic treatment.

This months over-the-counter (OTC) product guide highlights products that contain natural ingredients.

Challenges for uptake of long-acting injectable pre-exposure prophylaxis in populations at risk for HIV include fear of needles, potential adverse effects, and concerns about diminished efficacy.

Research into how perivascular spaces contribute to migraine could help better understand the complexities of how these headaches occur.

Treatment with immune checkpoint inhibitors have the potential for immune-related adverse events, such as psoriasis.

Derazantinib is an investigational oral inhibitor of FGFR1, FGFR2, and FGFR3 in patients with locally advanced or metastatic intrahepatic cholangiocarcinoma.

On this month's list of Rx products is an FDA-updated label for a cardiovascular disease drug, 2 FDA-approved NDAs for schizophrenia and alopecia areata, and an FDA approved treatment for pustular psoriasis.

List of our November 2022 picks for generic products.